China’s Innovent Biologics looks to raise up to $422 million in HK IPO: sources

HONG KONG (Reuters) – Chinese biotech firm Innovent Biologics is looking to raise up to $422 million in its Hong Kong IPO, three sources said, in what could be the biggest biotech IPO in the financial …
( read original story …)



Related Post